ACCESSION: MSBNK-SMB_Measured-HSA015P0256002
RECORD_TITLE: Annotated; Palmitic amide; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was annotated at Level 2a automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 24
COMMENT: RAW_SPEC {'EL03_pos_10189': {'bp': 338385.0, 'sum': 1102208.0}, 'EL17_pos_10240': {'bp': 144353.0, 'sum': 528081.0}, 'EL23_pos_10227': {'bp': 138520.0, 'sum': 424731.0}, 'EL15_pos_10257': {'bp': 137265.0, 'sum': 465386.0}, 'EL13_pos_10234': {'bp': 135359.0, 'sum': 438980.0}, 'EL09_pos_10229': {'bp': 135050.0, 'sum': 461900.0}, 'EL16_pos_10222': {'bp': 131034.0, 'sum': 438937.0}, 'EL20_pos_10221': {'bp': 130176.0, 'sum': 427656.0}, 'Blanc3-pos_10138': {'bp': 126577.0, 'sum': 376929.0}, 'EL07_pos_10216': {'bp': 125005.0, 'sum': 403271.0}, 'EL06_pos_10253': {'bp': 123668.0, 'sum': 435170.0}, 'EL21_pos_10246': {'bp': 123460.0, 'sum': 444817.0}, 'EL12_pos_10258': {'bp': 123269.0, 'sum': 422083.0}, 'EL10_pos_10217': {'bp': 122892.0, 'sum': 403729.0}, 'EL01_pos_10216': {'bp': 121483.0, 'sum': 437225.0}, 'EL11_pos_10217': {'bp': 121455.0, 'sum': 379099.0}, 'EL05_pos_10287': {'bp': 119660.0, 'sum': 455727.0}, 'EL14_pos_10241': {'bp': 118653.0, 'sum': 440594.0}, 'EL24_pos_10223': {'bp': 115202.0, 'sum': 385713.0}, 'EL08_pos_10227': {'bp': 114610.0, 'sum': 394687.0}, 'EL02_pos_10307': {'bp': 113814.0, 'sum': 520738.0}, 'EL19_pos_10305': {'bp': 113253.0, 'sum': 452048.0}, 'EL04_pos_10211': {'bp': 109603.0, 'sum': 379368.0}, 'EL18_pos_10222': {'bp': 100934.0, 'sum': 403797.0}}
COMMENT: RETENTION_TIME_STDEV 0.010
COMMENT: PRECURSOR_M/Z_RAW 256.263550
COMMENT: PRECURSOR_M/Z_STDEV 0.000083
COMMENT: PRECURSOR_IN_MS1 mz 256.263502; int 43.488; delta(ppm) 1.270005
COMMENT: PROPOSED_CHARGE_STATE +1; mz 257.266836; int 7.734; cor 0.627
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+IsoProp+H; M+CH3OH+H; mz 228.232100; int 13.155; cor 0.633
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.047; C16H33NO; [M+H]+; delta(ppm) 0.047012
COMMENT: PROPOSED_MF SevenGoldenRules 2.751; C13H25N; [M+IsoProp+H]+; delta(ppm) -2.751050
COMMENT: PROPOSED_MF MS-FINDER 3.334; C16H33NO; [M+H]+; delta(ppm) 0.046382
COMMENT: PROPOSED_MF MS-FINDER 3.192; C13H25N; [M+IsoProp+H]+; delta(ppm) 128020.954883
COMMENT: PROPOSED_MF SIRIUS5_Sirius 9.772; C16H33NO; [M+H]+; delta(ppm) 0.046382
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C16H33NO; [M+H]+; delta(ppm) 0.046382
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.465; C16H33NO; [M+H]+; delta(ppm) 0.046382
COMMENT: PROPOSED_MF SIRIUS6_Sirius -3.602; C14H31N4; [M+H]+; delta(ppm) 5.285797
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C16H33NO; [M+H]+; delta(ppm) 0.046382
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 6.000; HSEMFIZWXHQJAE-UHFFFAOYSA-N; C16H33NO; Spectral Match to Palmitamide from NIST14
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; LOTNCCWXPMLJSC-UHFFFAOYSA-N; C16H33NO; amylamine-C11:0
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.279; KJXSXHGTHSJJMJ-UHFFFAOYSA-N; [M+H]+; O=C(NCC(C)C)CCCCCCCCCCC
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.769; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; CCCCCCCCCCCCCCCC(N)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.714; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; Palmitic amide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.456; WKJHMKQSIBMURP-UHFFFAOYSA-N; [M+IsoProp+H]+; UNPD191157
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.435; HXFZUTUAOVWNHP-PCRUOVEUNA-N; [M+IsoProp+H]+; UNPD180520
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.411; PSGDYNNBBROEEW-YCOSTAMYNA-N; [M+IsoProp+H]+; UNPD58766
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.404; KJXSXHGTHSJJMJ-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.364; SVRHEGFQZHQVHY-STGVRZAANA-N; [M+IsoProp+H]+; UNPD143628
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.336; RYIVYPMKIOAJQP-STGVRZAANA-N; [M+IsoProp+H]+; UNPD34456
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.250; HFUFMWLNHRIKMV-PSENVYOBNA-N; [M+IsoProp+H]+; UNPD118012
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.230; XWIGNCVWEVRDAL-LJEKBPCBNA-N; [M+IsoProp+H]+; UNPD98403
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; KJXSXHGTHSJJMJ-UHFFFAOYSA-N; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.966; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; Palmitic amide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.966; HSEMFIZWXHQJAE-UHFFFAOYSA-N; [M+H]+; hexadecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.831; CWNSVVHTTQBGQB-UHFFFAOYSA-N; [M+H]+; N,N-diethyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.632; ZRIILUSQBDFVNY-UHFFFAOYSA-N; [M+H]+; 4-dodecylmorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.612; FQXSTGKJHBFSIQ-UHFFFAOYSA-N; [M+H]+; N,N-dimethyltetradecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.211; NTHVNXBUGUHNAH-UHFFFAOYSA-N; [M+H]+; N-butyldodecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; XRGQSRGEPOBQIF-UHFFFAOYSA-N; [M+H]+; N,N-dipropyldecanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.078; YJJHHUIJWCCSFA-UHFFFAOYSA-N; [M+H]+; N,N-dibutyl-2-propylpentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.907; TWEPVARUEREPAN-UHFFFAOYSA-N; [M+H]+; 2-propyl-N-(2-propylpentyl)pentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -19.819; HSEMFIZWXHQJAE; [M+H]+; Amide 16
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -53.451; NTHVNXBUGUHNAH; [M+H]+; Lauramide, N-butyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -64.560; KJXSXHGTHSJJMJ; [M+H]+; N-(2-methylpropyl)dodecanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.415; CWNSVVHTTQBGQB; [M+H]+; Diethyllauramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -136.634; FQXSTGKJHBFSIQ; [M+H]+; Dimethyl myristamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -144.604; IRACWGPKDYUZEC; [M+H]+; N,N-Dibutyloctanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.702; OVFJYDPLMRSSML; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.721; TWEPVARUEREPAN; [M+H]+; 2-propyl-n-(2-propylpentyl)pentanamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.794; YJJHHUIJWCCSFA; [M+H]+; N,N-Dibutyl-2-propylvaleramide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -236.721; ZRIILUSQBDFVNY; [M+H]+; Dodecyl morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.759; HSEMFIZWXHQJAE; [M+H]+; Amide 16
COMMENT: CONFIDENCE Level 2a: Probable structure by library spectrum match Palmitic amide, HSEMFIZWXHQJAE-UHFFFAOYSA-N; Matching to 6 measured spectra (Dot product > 0.7); Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (2), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0012273;
CH$NAME: Palmitic amide
CH$NAME: hexadecanamide
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C16H33NO
CH$EXACT_MASS: 255.256215
CH$SMILES: CCCCCCCCCCCCCCCC(=O)N
CH$IUPAC: InChI=1S/C16H33NO/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16(17)18/h2-15H2,1H3,(H2,17,18)
CH$LINK: CHEBI CHEBI:74475
CH$LINK: HMDB HMDB0012273
CH$LINK: INCHIKEY HSEMFIZWXHQJAE-UHFFFAOYSA-N
CH$LINK: LIPIDMAPS LMFA08010009
CH$LINK: PUBCHEM CID:69421
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 16.677
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 256.263503
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-2090000000-4c6985e006c941bff353
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  55.0544661 49.3364 55.055174 0.6721 9.02 0.1245 23 f{C4H7}/4.35ppm,p-C12H27N1O1
  57.0701423 136.2431 57.070859 0.6483 19.72 0.6087 24 f{C4H9}/4.65ppm,p-C12H25N1O1
  67.0543339 37.9244 67.055075 0.9395 12.74 0.3913 24 f{C5H7}/1.60ppm,p-C11H27N1O1
  69.0700156 69.5120 69.070759 1.0279 12.46 0.4466 22 f{C5H9}/2.01ppm,p-C11H25N1O1
  71.0856251 50.7818 71.086368 0.9566 7.28 0.6061 24 f{C5H11}/1.38ppm,p-C11H23N1O1
  81.0699293 36.0001 81.070656 1.2582 9.48 0.3400 23 f{C6H9}/0.65ppm,p-C10H25N1O1
  83.0855946 47.6926 83.086314 0.6860 6.91 0.3203 20 f{C6H11}/0.82ppm,p-C10H23N1O1
  88.0756945 43.2938 88.076391 0.8970 9.07 0.4615 23 f{C4H10N1O1}/0.05ppm,p-C12H24
  95.0855559 66.4718 95.086208 0.7467 17.44 0.7522 24 f{C7H11}/0.31ppm,p-C9H23N1O1
  97.1012084 36.0887 97.101845 0.7312 8.47 0.0579 19 f{C7H13}/0.33ppm,p-C9H21N1O1
  109.1011891 21.0256 109.101718 1.3565 5.94 0.2129 22 f{C8H13}/0.11ppm,p-C8H21N1O1
  121.0284074 99.4201 121.028837 1.0246 55.52 -0.0391 20 ?
  227.1428817 73.5804 227.143257 0.8717 10.72 0.0760 17 f{C16H19O1}/-0.70ppm,p-H15N1
  227.2369116 41.1399 227.237287 1.1046 10.23 0.3961 21 f{C15H31O1}/-0.13ppm,p-C1H3N1
  241.1587606 71.1709 241.159121 1.6213 11.49 0.3088 19 ?
  242.1661738 120.7487 242.166535 1.2842 14.25 -0.1800 24 ?
  255.2106127 44.3989 255.210986 1.4576 20.86 0.5312 21 ?
  256.2634310 392.2108 256.263805 0.3785 65.89 1.0000 24 f{C16H34N1O1}/-0.23ppm,p
  256.2995848 147.3200 256.299959 0.5111 28.37 -0.0513 24 ?
  257.1898931 999.0000 257.190268 0.3849 0.00 0.0739 24 ?
  258.1934307 176.5666 258.193806 0.9102 15.68 -0.0582 22 ?
  258.2790965 114.4780 258.279472 1.2390 26.89 -0.5833 22 ?
PK$NUM_PEAK: 22
PK$PEAK: m/z int. rel.int.
  55.054466 49.34 49
  57.070142 136.24 136
  67.054334 37.92 37
  69.070016 69.51 69
  71.085625 50.78 50
  81.069929 36.00 36
  83.085595 47.69 47
  88.075695 43.29 43
  95.085556 66.47 66
  97.101208 36.09 36
  109.101189 21.03 21
  121.028407 99.42 99
  227.142882 73.58 73
  227.236912 41.14 41
  241.158761 71.17 71
  242.166174 120.75 120
  255.210613 44.40 44
  256.263431 392.21 392
  256.299585 147.32 147
  257.189893 999.00 999
  258.193431 176.57 176
  258.279097 114.48 114
//
